Customized research for FPRX vs. BPMX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for FPRX vs. BPMX.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Five Prime Therapeutics, Inc. vs. BioPharmX Corporation

FPRX
Data Last Updated: 1 day ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 193.435M


P/E: N/A

P/S: 13.01

Q P/B: 1.44

Y Rev: 14.87M

Q Rev: 8.41M

Beta: 2.78

Industry

Health Care/Life Sciences

FPRX Share Stats

Outstanding Shares

36.64M

Float Shares

35.40M

Percent of Float Short

3.75%

FPRX Insider Stats

Percent Outstanding Insider Ownership

3.56%

Percent Outstanding Institution Ownership

27.76%

FPRX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FPRX in Pulse Portal

Stream of Posts

FPRX Symbol Page

Share FPRX Insights

Express Sentiment

'Buy' or 'Sell' FPRX

FPRX Profile

CEO

Mr. William R. Ringo

Exchange

Nasdaq

Employees

87.00

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. Its product candidates includes, Cabiralizumab(FPA008), Bemarituzumab(FPA144), and FPA150. The FPA008 is an antibody that...

FPRX Financials

Annual Financials

Income Statement

Revenue

14.87M

Net Income

(137.2M)

Cash Flow Statement

Change in Cash / Investments

11.85M

Balance Sheet

Cash / Investments

156.38M

Short Term Debt

4.08M

Long Term Debt

None

Total Current Assets

166.72M

Total Current Liabilities

23.02M

Total Assets

224.14M

Total Liabilities

73.67M

Stockholder Equity

150.47M

Quarterly Financials

Income Statement

Q Revenue

8.41M

Q Net Income

(20.12M)

Cash Flow Statement

Q Change in Cash / Investments

11.89M

Balance Sheet

Q Cash / Investments

141.13M

Q Short Term Debt

4.22M

Q Long Term Debt

None

Q Total Current Assets

150.29M

Q Total Current Liabilities

19.21M

Q Total Assets

202.97M

Q Total Liabilities

68.43M

Q Stockholder Equity

134.54M

FPRX Charts

10-Year Chart

FPRX 10-Year Chart

5-Year Chart

FPRX 5-Year Chart

1-Year Chart

FPRX 1-Year Chart

6-Month Chart

FPRX 6-Month Chart

3-Month Chart

FPRX 3-Month Chart

1-Month Chart

FPRX 1-Month Chart

1-Day Chart

FPRX 1-Day Chart

BPMX
Data Last Updated: 4 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 776,821


P/E: N/A

P/S: N/A

Q P/B: N/A

Y Rev: N/A

Q Rev: N/A

Beta: N/A

Industry

2,974,693

BPMX Share Stats

Outstanding Shares

0.

Float Shares

0.

Percent of Float Short

N/A

BPMX Insider Stats

Percent Outstanding Insider Ownership

9.94%

Percent Outstanding Institution Ownership

1.22%

BPMX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

BPMX in Pulse Portal

Stream of Posts

BPMX Symbol Page

Share BPMX Insights

Express Sentiment

'Buy' or 'Sell' BPMX

BPMX Profile

CEO

Home

Exchange

NYSE American

Employees

N/A

About

BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environme...

BPMX Financials

Annual Financials

Income Statement

Revenue

N/A

Net Income

N/A

Cash Flow Statement

Change in Cash / Investments

N/A

Balance Sheet

Cash / Investments

N/A

Short Term Debt

N/A

Long Term Debt

N/A

Total Current Assets

N/A

Total Current Liabilities

N/A

Total Assets

N/A

Total Liabilities

N/A

Stockholder Equity

N/A

Quarterly Financials

Income Statement

Q Revenue

N/A

Q Net Income

N/A

Cash Flow Statement

Q Change in Cash / Investments

N/A

Balance Sheet

Q Cash / Investments

N/A

Q Short Term Debt

N/A

Q Long Term Debt

N/A

Q Total Current Assets

N/A

Q Total Current Liabilities

N/A

Q Total Assets

N/A

Q Total Liabilities

N/A

Q Stockholder Equity

N/A

BPMX Charts

10-Year Chart

BPMX 10-Year Chart

5-Year Chart

BPMX 5-Year Chart

1-Year Chart

BPMX 1-Year Chart

6-Month Chart

BPMX 6-Month Chart

3-Month Chart

BPMX 3-Month Chart

1-Month Chart

BPMX 1-Month Chart

1-Day Chart

BPMX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon